Dermata Therapeutics, Inc. (DRMA)
NASDAQ: DRMA · Real-Time Price · USD
0.7940
-0.0164 (-2.02%)
At close: May 12, 2025, 4:00 PM
0.7800
-0.0140 (-1.76%)
After-hours: May 12, 2025, 5:16 PM EDT
Dermata Therapeutics Market Cap
Dermata Therapeutics has a market cap or net worth of $4.31 million as of May 12, 2025. Its market cap has increased by 81.43% in one year.
Market Cap
4.31M
Enterprise Value
1.15M
1-Year Change
81.43%
Ranking
Category
Stock Price
$0.79
Market Cap Chart
Since the IPO on August 13, 2021, Dermata Therapeutics's market cap has decreased from $57.49M to $4.31M, a decrease of -92.50%. That is a compound annual growth rate of -49.97%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 9, 2025 | 4.40M | 59.74% |
| Dec 31, 2024 | 2.76M | 27.62% |
| Dec 29, 2023 | 2.16M | -56.39% |
| Dec 30, 2022 | 4.95M | -65.84% |
| Dec 31, 2021 | 14.49M | -74.79% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 659.45B |
| Johnson & Johnson | 371.06B |
| UnitedHealth Group | 345.29B |
| AbbVie | 326.08B |
| Novo Nordisk | 297.79B |
| Abbott Laboratories | 231.82B |
| Novartis AG | 214.71B |
| AstraZeneca | 211.14B |